Cargando…

Functional Characterization of the MYO6 Variant p.E60Q in Non-Syndromic Hearing Loss Patients

Hereditary hearing loss (HHL) is a common genetic disorder accounting for at least 60% of pre-lingual deafness in children, of which 70% is inherited in an autosomal recessive pattern. The long tradition of consanguinity among the Qatari population has increased the prevalence of HHL, which negative...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkowari, Moza, Espino-Guarch, Meritxell, Daas, Sahar, Abdelrahman, Doua, Hasan, Waseem, Krishnamoorthy, Navaneethakrishnan, Sathappan, Abbirami, Sheehan, Patrick, Van Panhuys, Nicholas, Estivill, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949016/
https://www.ncbi.nlm.nih.gov/pubmed/35328790
http://dx.doi.org/10.3390/ijms23063369
_version_ 1784674793300164608
author Alkowari, Moza
Espino-Guarch, Meritxell
Daas, Sahar
Abdelrahman, Doua
Hasan, Waseem
Krishnamoorthy, Navaneethakrishnan
Sathappan, Abbirami
Sheehan, Patrick
Van Panhuys, Nicholas
Estivill, Xavier
author_facet Alkowari, Moza
Espino-Guarch, Meritxell
Daas, Sahar
Abdelrahman, Doua
Hasan, Waseem
Krishnamoorthy, Navaneethakrishnan
Sathappan, Abbirami
Sheehan, Patrick
Van Panhuys, Nicholas
Estivill, Xavier
author_sort Alkowari, Moza
collection PubMed
description Hereditary hearing loss (HHL) is a common genetic disorder accounting for at least 60% of pre-lingual deafness in children, of which 70% is inherited in an autosomal recessive pattern. The long tradition of consanguinity among the Qatari population has increased the prevalence of HHL, which negatively impacts the quality of life. Here, we functionally validated the pathogenicity of the c.178G>C, p.E60Q mutation in the MYO6 gene, which was detected previously in a Qatari HHL family, using cellular and animal models. In vitro analysis was conducted in HeLa cells transiently transfected with plasmids carrying MYO6(W)(T) or MYO6(p.E60Q), and a zebrafish model was generated to characterize the in vivo phenotype. Cells transfected with MYO6(WT) showed higher expression of MYO6 in the plasma membrane and increased ATPase activity. Modeling the human MYO6 variants in zebrafish resulted in severe otic defects. At 72 h post-injection, MYO6(p.E60Q) embryos demonstrated alterations in the sizes of the saccule and utricle. Additionally, zebrafish with MYO6(p.E60Q) displayed super-coiled and bent hair bundles in otic hair cells when compared to control and MYO6(WT) embryos. In conclusion, our cellular and animal models add support to the in silico prediction that the p.E60Q missense variant is pathogenic and damaging to the protein. Since the c.178G>C MYO6 variant has a 0.5% allele frequency in the Qatari population, about 400 times higher than in other populations, it could contribute to explaining the high prevalence of hearing impairment in Qatar.
format Online
Article
Text
id pubmed-8949016
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89490162022-03-26 Functional Characterization of the MYO6 Variant p.E60Q in Non-Syndromic Hearing Loss Patients Alkowari, Moza Espino-Guarch, Meritxell Daas, Sahar Abdelrahman, Doua Hasan, Waseem Krishnamoorthy, Navaneethakrishnan Sathappan, Abbirami Sheehan, Patrick Van Panhuys, Nicholas Estivill, Xavier Int J Mol Sci Article Hereditary hearing loss (HHL) is a common genetic disorder accounting for at least 60% of pre-lingual deafness in children, of which 70% is inherited in an autosomal recessive pattern. The long tradition of consanguinity among the Qatari population has increased the prevalence of HHL, which negatively impacts the quality of life. Here, we functionally validated the pathogenicity of the c.178G>C, p.E60Q mutation in the MYO6 gene, which was detected previously in a Qatari HHL family, using cellular and animal models. In vitro analysis was conducted in HeLa cells transiently transfected with plasmids carrying MYO6(W)(T) or MYO6(p.E60Q), and a zebrafish model was generated to characterize the in vivo phenotype. Cells transfected with MYO6(WT) showed higher expression of MYO6 in the plasma membrane and increased ATPase activity. Modeling the human MYO6 variants in zebrafish resulted in severe otic defects. At 72 h post-injection, MYO6(p.E60Q) embryos demonstrated alterations in the sizes of the saccule and utricle. Additionally, zebrafish with MYO6(p.E60Q) displayed super-coiled and bent hair bundles in otic hair cells when compared to control and MYO6(WT) embryos. In conclusion, our cellular and animal models add support to the in silico prediction that the p.E60Q missense variant is pathogenic and damaging to the protein. Since the c.178G>C MYO6 variant has a 0.5% allele frequency in the Qatari population, about 400 times higher than in other populations, it could contribute to explaining the high prevalence of hearing impairment in Qatar. MDPI 2022-03-21 /pmc/articles/PMC8949016/ /pubmed/35328790 http://dx.doi.org/10.3390/ijms23063369 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alkowari, Moza
Espino-Guarch, Meritxell
Daas, Sahar
Abdelrahman, Doua
Hasan, Waseem
Krishnamoorthy, Navaneethakrishnan
Sathappan, Abbirami
Sheehan, Patrick
Van Panhuys, Nicholas
Estivill, Xavier
Functional Characterization of the MYO6 Variant p.E60Q in Non-Syndromic Hearing Loss Patients
title Functional Characterization of the MYO6 Variant p.E60Q in Non-Syndromic Hearing Loss Patients
title_full Functional Characterization of the MYO6 Variant p.E60Q in Non-Syndromic Hearing Loss Patients
title_fullStr Functional Characterization of the MYO6 Variant p.E60Q in Non-Syndromic Hearing Loss Patients
title_full_unstemmed Functional Characterization of the MYO6 Variant p.E60Q in Non-Syndromic Hearing Loss Patients
title_short Functional Characterization of the MYO6 Variant p.E60Q in Non-Syndromic Hearing Loss Patients
title_sort functional characterization of the myo6 variant p.e60q in non-syndromic hearing loss patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949016/
https://www.ncbi.nlm.nih.gov/pubmed/35328790
http://dx.doi.org/10.3390/ijms23063369
work_keys_str_mv AT alkowarimoza functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT espinoguarchmeritxell functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT daassahar functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT abdelrahmandoua functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT hasanwaseem functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT krishnamoorthynavaneethakrishnan functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT sathappanabbirami functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT sheehanpatrick functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT vanpanhuysnicholas functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients
AT estivillxavier functionalcharacterizationofthemyo6variantpe60qinnonsyndromichearinglosspatients